Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas

NCT00788099 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Lymphomas

Interventions

DRUG: Plitidepsin and Sorafenib
DRUG: Gemcitabine and Plitidepsin

Sponsor

PharmaMar